Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 04/20/2009 - 04/20/2012

This course is closed. Please look for other available products in CPNP University.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Attention Deficit Hyperactivity Disorder is a common neuropsychiatric condition impacting 4.4% of the adult population age 18-44 according to a recent epidemiological survey. As in childhood, the condition is often marked by challenges with attention, organization and forgetfulness, although adults who were hyperactive as children often grow out of physical hyperactivity. There is evidence that ADHD is associated with poorer outcomes in domestic and occupational endeavors, as well as higher rates of motor vehicle accidents.

Assessment requires clinical evaluation of whether the patient meets criteria for the DSM-IV symptoms of ADHD, with adult manifestation. Comorbid mental health conditions are more common in individuals with ADHD, compounding the distress experienced by individuals with the condition. Prominent comorbid mental health conditions may require prioritized management.

Stimulant and non-stimulant pharmacologic interventions have demonstrated efficacy for ADHD management. These agents all share similar side effect patterns (physical discomforts and mild cardiovascular effects) and contraindications (particularly conditions that would be exacerbated by increased sympathetic nervous system activity). Tolerability of these agents is maximized by gradual dose increase, avoidance of other sympathomimetic agents, and trials as needed of different release patterns of an effective agent. Long-acting preparations are preferable to short acting agents due to ease of daylong coverage and evidence for higher rates of diversion or misuse of short acting agents. Adequacy of interventions is optimized by identifying treatment goals related to ADHD symptoms, and serial screening of symptoms. Data is emerging on non-pharmacologic interventions, including cognitive-behavioral approaches as adjuncts to pharmacotherapy interventions.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Compare and contrast the clinical presentation of attention-deficit hyperactivity disorder (ADHD) in children and adults.
  2. Apply evidence-based strategies for screening, diagnosing, and monitoring of ADHD in adult patients.
  3. Evaluate the efficacy and outcomes of traditional and new drug therapies for the management of adult patients with ADHD.

Continuing Education Credit and Disclosures

Activity Dates: 04/20/2009 - 04/20/2012
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-09-007-H01-P
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-09-007-L01-P (1.0 contact hours).

ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:

  1. Continuing nursing education (CNE) approved for nursing contact hours by an accredited provider or approver of nursing continuing education
  2. Continuing medical education (CME) approved for CME hours
  3. Sponsored by organizations, agencies, or educational institutions accredited or approved by the American Nurses Credentialing Center (ANCC) or the Accreditation Council for Continuing Medical Education (ACCME) or the Accreditation Council for Pharmacy Education (ACPE) or the Commission on Dietetic Registration

Grant Support

This programming was supported in part by grants from Bristol-Myers Squibb, Forest Laboratories, Inc., Lilly, Schering-Plough, Cyberonics, Shire, and Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Annual Meeting Grant Supporter

Recertification Education Grant Provider

Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC.